WUHU, China, Oct. 27, 2025 /PRNewswire/ — During the 2025 Chery International User Summit, Mr. Ban Ki-moon, the 8th Secretary-General of the United Nations, visited Wuhu and toured the world’s first LEPAS Elegant Lifestyle House, viewing the LEPAS L8, LEPAS L6, and LEPAS L4 up close and sharing valuable insights on sustainability.

JeryL Lee, Malaysia’s rising pop star, also visited the LEPAS Elegant Lifestyle House to experience the brand’s “Elegant Life” philosophy firsthand. At the Chery International User Carnival, she appeared in the LEPAS L8, delivering captivating performance that strengthened LEPAS’s emotional connection with Southeast Asian consumers. Ybg. Mr. NG KAI SENG, Minister-Counsellor of the Embassy of Malaysia in China, also attended the summit, witnessing LEPAS’s remarkable “Elegant Driving” performance and its milestone in global expansion.

LEPAS made its international debut at the Indonesia International Auto Show (GIIAS) in Jakarta, officially launching its journey into the Southeast Asian market. With a full lineup of the three models, and a colorful booth, LEPAS’s exhibition drew widespread attention. The LEPAS L8, as the flagship model, embodies refined power and versatility; the LEPAS L6 represents smart sophistication, balancing intelligence and beauty; while the LEPAS L4, the new urban icon, captures youthful agility and style. Together, they vividly express LEPAS’s signature “Leopard Aesthetics”.

Positioned as the“Preferred Brand for Elegant Mobility Life, “LEPAS upholds its philosophy of“Drive Your Elegance,”to make every journey elegant. The brand name LEPAS carries three meanings: LE (Leopard) symbolizes the perfect fusion of speed, power, and grace, echoing the brand’s “Leopard Aesthetics”and technological mastery; LEAP reflects its global vision, transcending geographical and cultural boundaries; and PASSION conveys energy and inspiration, encouraging urban elites to explore refined, tech-driven lifestyles. The visits by Ban Ki-moon and JeryL Lee showcased how Chinese new energy brands are stepping onto the global stage. Guided by Chery Group’s global vision of “In somewhere, For somewhere, Be somewhere, “LEPAS will continue to deepen its presence in Southeast Asia, using LEPAS Elegant Technology and green mobility to empower every journey and light up the “Elegant Life” for users worldwide.

SINGAPORE, Oct. 27, 2025 /PRNewswire/ — Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of Understanding (MOU) on 22 October 2025 to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia.

Under this partnership, the Group and Gene Solutions will collaborate to identify patients eligible for pharma-sponsored clinical trials. Patients undergoing Comprehensive Genomic Profiling (CGP) via Gene Solutions will be automatically screened for eligibility. The Group’s Clinical Trials Unit will collaborate closely with local oncologists to facilitate patient enrolment. This initiative aims to make cutting-edge cancer treatments more accessible and support more equitable access to clinical trials across the region.

Empowering patients with new opportunities

Through this collaboration, patients in Vietnam and Southeast Asia will have improved opportunities to join innovative cancer studies without traditional barriers. From initial genetic testing and eligibility screening to ongoing clinical care and assistance, patients and their families will receive guidance to navigate complex treatment journeys with confidence and clarity.

Understanding precision medicine

Modern cancer treatments are moving beyond “one-size-fits-all” approaches. Precision therapies, such as targeted drugs and immunotherapies, work by focusing on specific genetic changes or immune pathways that drive cancer growth. While many targeted therapies are already approved, there are still numerous genes and mutations without effective drugs. This is why more clinical trials are essential to evaluate new treatments and bring more hope to patients.

As Gene Solutions’ signature oncology test, K-4CARE, states in its tagline: “Unveiling details, unlocking hope”—the more we understand about a tumor’s DNA and RNA profile, the greater the chance patients have of accessing approved drugs or joining global clinical trials. To identify these opportunities, doctors need to look deep into the tumor’s genetic code. This is where Next Generation Sequencing (NGS) comes in. Gene Solutions uses NGS to decode the cancer’s genetic profile and pinpoint patients who may respond to advanced treatments. Without this testing, many patients would never know they qualify for life-changing clinical trials.

Expert perspective

Professor Yasuo Saijo, Medical Oncologist at Raffles Medical Indochina, shared: “For oncologists, genomic insights are transforming how we approach cancer care. By understanding the tumor’s genetic and transcriptomic profile, we can make more informed decisions, such as selecting the right therapy at the right time, tailoring treatment to each patient’s unique biology, and improving both outcomes and quality of life.”

Raffles’ dedicated Clinical Trials Unit

Raffles Medical Group brings decades of experience in delivering high-quality cancer care and conducting clinical trials. Through its Raffles Cancer Centre and dedicated Clinical Trials Unit, the Group has participated in more than 50 international studies, ensuring patients receive access to promising therapies under the highest standards of safety and ethics. Its multi-disciplinary approach and advanced facilities in Singapore make it a trusted destination for complex cancer care and innovative treatments across Southeast Asia.

First step: KRYSTAL-7

The collaboration will begin with KRYSTAL-7, a global study enrolling participants diagnosed with non-small cell lung cancer (NSCLC) with KRAS G12C mutation who have received no prior treatments. This is the first of many clinical trials planned under the partnership, reflecting a shared commitment to improving patient outcomes through innovation and international cooperation.

“Raffles Medical Group is delighted to partner with Gene Solutions to bring cutting-edge clinical trials to patients in Vietnam and across Southeast Asia. This collaboration reflects our commitment to advancing precision medicine and improving patient outcomes,” says Mr. Wilson Lai, General Manager of Raffles Medical Indochina.

“With one of the largest market shares for comprehensive genomic profiling across Southeast Asia, Gene Solutions can pre-screen a vast pool of patients and identify those who may benefit from clinical trials. By combining this capability with Raffles’ clinical excellence, we can accelerate access to promising new therapies for patients throughout the region,” says Dr. Nguyen Huu Nguyen, Co-founder and Deputy CEO of Gene Solutions.

About Gene Solutions

Gene Solutions is a multinational biotechnology company at the forefront of genetic testing and research innovation across the Asia-Pacific region. Leveraging Next-Generation Sequencing (NGS) and Artificial Intelligence, the company offers a comprehensive portfolio of advanced solutions, including:

• Next-generation non-invasive prenatal testing (NIPT), which covers both fetal abnormalities and maternal health indicators.
• Clinically validated multi-cancer screening using multi-omics circulating tumor DNA (ctDNA) technology for early detection and tumor-of-origin localization.
• Comprehensive genomic and transcriptomic profiling combined with clinically validated ctDNA-based molecular residual disease (MRD) monitoring to guide precision treatment and track disease progression.

With over two million genetic tests delivered since 2017, Gene Solutions is recognized for its proprietary research, CAP-accredited laboratories, and contributions to advancing precision medicine through clinical studies, technology development, and regional collaborations. For more information, please visit genesolutions.com.

About Raffles Medical Group

Founded in 1976, Raffles Medical Group is one of the leading integrated private healthcare providers in the region, providing a continuum of services from primary and tertiary care to health insurance for people across Asia. A proudly Singaporean brand, RMG is listed on the mainboard of the Singapore stock exchange (SGX: BSL) and operates in 14 cities in five countries in Asia. This network includes four hospitals and over 100 multi-disciplinary clinics, offering services such as health screening, specialist care, diagnostic radiology, dental and traditional Chinese medicine. Together with about 2,900 employees, RMG brings over 48 years of trusted healthcare expertise and care to more than 2.8 million patients across our network as their trusted partner for health. For more information, please visit rafflesmedicalgroup.com.

MACAO, Oct. 27, 2025 /PRNewswire/ — CreatorWeek Macao 2025, co-organized by Macao Government Tourism Office (MGTO) and Branded, with Adbeyond Group Macau as a collaborative partner, is currently taking place from October 24 to 28. The event is transforming the city into a vibrant showcase of global creativity. With more than 180 creator groups, 50 keynote speakers, and 20 live acts gathering from around the world, the event is drawing wide attention as Macao’s first large-scale celebration of the creator economy.

The CreatorWeek opening party on October 24 at Wynn Palace set the stage for a week unfolding with creative energy and international dialogue. Participants shared creative insights and explored how diverse stories can be expressed globally through new content formats. The event fostered a vibrant exchange where Chinese creators shared their traditions and modern perspectives, while international creators reinterpreted these narratives for worldwide audiences. Through interactive experiences, attendees highlighted Macao’s creative vitality, and its unique position as a crossroads of East and West.

The CreatorWeek Conference, taking place on October 27-28 at the Grand Lisboa Palace Resort Macau, will unite creators, social media leaders, and representatives from Google, Bilibili, Meta, YouTube, Red, and Douyin. Notable guests such as Stokes Twins and Alan Chikin Chow are joining discuss on East-West community differences, monetization, and cross-cultural collaboration, reinforcing Macao’s role as a creative hub.

Participants are immersed in sessions beyond digital production. Wellness Workshops are underway at MGM’s Fantasy Box, with creators like Will Liu and Matt Tralli leading participants through a series of wellness training sessions, while the Meet and Greet on October 25–26 at The Londoner Macao are drawing hundreds of fans for close-up interactions with 40 popular creators including Apl.de.Ap, Steven He, and Berywam.

Meanwhile, Galaxy Macau™ will take center stage for CreatorWeek Live, featuring performances by international stars such as K-pop group XODIAC, Japan’s Psychic Fever from EXILE TRIBE, and the Philippines’ Mikey Bustos. The CreatorWeek Academy will launch a series of practical workshops, featuring industry experts and leading platform representatives sharing insights on content creation and strategies for expanding into global markets.

A special Local Community Tour pairs international creators with local ambassadors to explore the city’s neighborhoods, cuisine, and culture, creating collaborative content that broadcasts Macao’s spirit to global audiences.

“CreatorWeek Macao 2025 is unveiling Macao’s unique glamour and rich multicultural heritage to the world. By propelling tourism through creativity, the event is injecting fresh energy into Macao’s transformation into a world centre of tourism and leisure,” remarked MGTO Director Maria Helena de Senna Fernandes.

For the latest updates and event livestreams, visit the official website at www.creatorweek.live or follow @visitmacao on Instagram, Facebook, YouTube, TikTok, and Red.

About Macao

Macao is a vibrant city known for its rich cultural heritage, world-class entertainment, and diverse culinary scene. As a premier travel destination, Macao offers a unique blend of East and West, where ancient traditions meet modern attractions.